Related Experiment Video
Updated: May 21, 2025
07:40
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.4K
A trial-blazer in clinical research.
Alex Johnston1, Arti Medhavy1, Suzanne Elliott2
1Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD, Australia.
Immunology and Cell Biology
|May 20, 2025
Summary
Gallipoli Medical Research advances healthcare through innovative treatments in oncology, liver, and respiratory diseases. Dr. Suzanne Elliott shares insights from her 30-year career in clinical trials.
Area of Science:
- Medical Research
- Clinical Trials
- Oncology
- Hepatology
- Pulmonology
Background:
- Gallipoli Medical Research (GMR) established in 2005, is an independent medical research institute in Brisbane, Queensland.
- GMR focuses on translating laboratory discoveries into real-world healthcare solutions.
- The institute launched its clinical trials program in 2006, specializing in oncology, liver, and respiratory diseases.
Purpose of the Study:
- To highlight the contributions of Dr. Suzanne Elliott, Associate Director of Clinical Trials at GMR.
- To document her transition from laboratory research to clinical trial leadership.
- To share her expertise and advice on the clinical trial landscape.
Main Methods:
- Qualitative discussion and career retrospective.
- Insight sharing on industry, government, and research contributions.
- Focus on a 30-year career in medical research and clinical trials.
Main Results:
- Dr. Elliott's extensive experience spans 30 years in medical research.
- She has made significant contributions to the clinical trial industry.
- Her insights offer valuable guidance for the field.
Conclusions:
- Dr. Elliott's career exemplifies the successful translation of research into clinical practice.
- GMR continues to be a leader in advancing treatments for major diseases.
- The insights shared provide a roadmap for future clinical trial development.
More Related Videos
Related Concept Videos
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
01:11Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K
01:22Case Studies
11.6K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.6K
01:16Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
01:12Hazard Ratio
72
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
72